Opportunity Information: Apply for RFA DK 23 006

The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), issued a discretionary grant opportunity titled "Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)" under funding opportunity number RFA-DK-23-006. This announcement uses the R01 research project grant mechanism and allows, but does not require, clinical trials, meaning applicants can propose basic science, translational, or clinical research projects depending on what best fits their aims. The overall focus is pain as it relates to diseases and conditions that fall within NIDDK's mission areas, with the agency emphasizing that pain can dramatically reduce quality of life for affected patients and that significant gaps remain in both scientific understanding and clinical management.

The core purpose of the opportunity is to stimulate investigator-initiated projects that generate new knowledge about why pain occurs, how it is maintained, and how it presents clinically in NIDDK-relevant disorders. NIDDK highlights that, even with prior research, the biological and clinical contributors of pain are still not well understood. In practical terms, the announcement is looking for studies that can clarify underlying mechanisms (for example, physiological, neurological, inflammatory, metabolic, or other disease-linked processes that drive pain), identify meaningful clinical features and contributors that shape patient experience, and connect these insights to improved ways of measuring, predicting, and treating pain. The intention is not only to improve scientific understanding of pain pathophysiology but also to translate that knowledge into better patient care.

A major theme is the need for new and improved pain management strategies. The announcement calls out the urgency of approaches that move beyond or improve upon existing interventions, explicitly referencing opioids as an example of current treatments that have limitations and risks. Applicants are encouraged to develop and test new approaches to assess pain (such as better measurement tools or methods to characterize pain more precisely), predict pain outcomes (including identifying factors that might indicate who is at risk for severe, persistent, or treatment-resistant pain), and target pain with safer or more effective interventions. Successful projects are expected to produce actionable insights that can foster improved treatment and pain management strategies for patients living with NIDDK-mission conditions.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other eligible entities. The announcement also explicitly notes additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

On the foreign eligibility side, the announcement draws a clear line: non-domestic (non-U.S.) entities and non-U.S. foreign institutions are not eligible to apply as the primary applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components are allowed as defined by the NIH Grants Policy Statement. In other words, while a foreign institution cannot serve as the main applicant, an otherwise eligible U.S. applicant may include certain foreign components when they are justified and compliant with NIH policy.

Administratively, this opportunity falls under the Health and related research category (listed under Food and Nutrition, Health) with CFDA number 93.847. The opportunity was created on February 10, 2023, and the original closing date was May 4, 2023. The notice does not provide an award ceiling or the expected number of awards in the provided source information, so applicants would typically rely on the full FOA text and NIH budget guidance for details on project period expectations, allowable costs, and any institute-specific budget preferences. Overall, the announcement is designed to push the field toward a more precise, mechanism-informed understanding of pain in NIDDK-relevant diseases and toward practical, improved methods to measure and manage pain that can ultimately translate into better patient outcomes.

  • The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
  • This funding opportunity was created on 2023-02-10.
  • Applicants must submit their applications by 2023-05-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DK 23 006

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is a discretionary NIH grant opportunity issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) titled "Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)" under funding opportunity number RFA-DK-23-006.

Which grant mechanism does this announcement use?

The announcement uses the NIH R01 research project grant mechanism.

Are clinical trials required for this R01?

No. Clinical trials are optional. Applicants may propose projects that include a clinical trial or projects that do not, depending on what best fits the proposed aims.

What is the main scientific focus of the opportunity?

The focus is on pain as it relates to diseases and conditions that fall within NIDDK mission areas. The opportunity emphasizes that pain can significantly reduce quality of life and that major gaps remain in understanding why pain occurs, how it is maintained, and how it presents clinically in NIDDK-relevant disorders.

What kinds of research projects are encouraged?

Investigator-initiated projects that generate new knowledge about pain in NIDDK-relevant diseases and conditions. The announcement indicates that basic science, translational, and clinical research approaches may be appropriate, as long as they align with the opportunity's goals.

What types of pain-related knowledge is NIDDK looking to advance through this FOA?

The FOA is intended to stimulate studies that clarify underlying mechanisms of pain, identify meaningful clinical features and contributors that shape patient experience, and link these insights to improved ways of measuring, predicting, and treating pain in NIDDK-mission disorders.

What does the announcement mean by "mechanisms" of pain?

Based on the description provided, "mechanisms" refers to underlying processes that may drive pain, such as physiological, neurological, inflammatory, metabolic, or other disease-linked processes that contribute to pain onset, persistence, and clinical presentation.

Does the opportunity prioritize translation to patient care?

Yes. The intent includes improving scientific understanding of pain pathophysiology and translating that knowledge into better patient care, including improved measurement and management strategies.

Is pain management strategy development part of the goal?

Yes. A major theme is the need for new and improved pain management strategies, with an emphasis on approaches that move beyond or improve upon existing interventions.

Does the announcement mention opioids?

Yes. Opioids are referenced as an example of current treatments that have limitations and risks, highlighting the urgency for safer or more effective approaches.

What types of pain assessment improvements are encouraged?

The announcement encourages development and testing of new approaches to assess pain, including better measurement tools or methods to characterize pain more precisely.

What does the FOA say about predicting pain outcomes?

It encourages approaches to predict pain outcomes, including identifying factors that may indicate who is at risk for severe, persistent, or treatment-resistant pain.

What kinds of intervention or treatment work is encouraged?

The FOA encourages work aimed at targeting pain with safer or more effective interventions, with the overall expectation that projects produce actionable insights that can foster improved treatment and pain management strategies.

Who is eligible to apply?

Eligibility is broad and includes many U.S.-based organizations and governmental entities. Eligible applicants include, among others: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other eligible entities.

Are minority-serving institutions and community-based organizations listed as eligible?

Yes. The announcement explicitly notes additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving Institutions, HBCUs, TCCUs, and faith-based or community-based organizations.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are explicitly listed among eligible applicant categories.

Can a non-U.S. (foreign) institution apply as the main applicant?

No. Non-domestic (non-U.S.) entities and non-U.S. foreign institutions are not eligible to apply as the primary applicant organization.

Can a U.S. applicant include foreign components in the project?

Yes. Non-domestic components of U.S. organizations are eligible, and foreign components are allowed as defined by the NIH Grants Policy Statement. A foreign institution cannot be the main applicant, but foreign components may be included when justified and compliant with NIH policy.

Which NIH institute is sponsoring this opportunity?

The opportunity is issued by NIH through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

What is the CFDA number and category listed for this opportunity?

The opportunity is listed under CFDA number 93.847 and falls under the Health and related research category (listed under Food and Nutrition, Health).

When was the opportunity created and when did it close?

The opportunity was created on February 10, 2023, and the original closing date was May 4, 2023.

Does the provided information include an award ceiling or expected number of awards?

No. The provided source information does not include an award ceiling or the expected number of awards.

What outcomes does NIDDK expect from successful projects?

Successful projects are expected to produce actionable insights that support improved ways to measure, predict, and manage pain for patients living with diseases and conditions in NIDDK mission areas, with the broader goal of improving patient outcomes.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition, Health

Next opportunity: Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)

Previous opportunity: F23AS00128 Cooperative Endangered Species Conservation Fund: HCP Land Acquisition

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 23 006

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 23 006) also looked into and applied for these:

Funding Opportunity
Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01 Clinical Trial Required) Apply for RFA DK 22 038

Funding Number: RFA DK 22 038
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed) Apply for RFA DK 22 037

Funding Number: RFA DK 22 037
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $375,000
Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) Apply for PAR 23 121

Funding Number: PAR 23 121
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $6,250,000
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) Apply for PAR 23 119

Funding Number: PAR 23 119
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $275,000
Human Liver Tissue and Hepatocytes Resource-Related Research Project (R24 Clinical Trial Not Allowed) Apply for RFA DK 23 012

Funding Number: RFA DK 23 012
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $2,500,000
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed) Apply for RFA DK 23 010

Funding Number: RFA DK 23 010
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $200,000
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed) Apply for RFA DK 23 009

Funding Number: RFA DK 23 009
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,200,000
Limited Competition for the NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed) Apply for RFA DK 22 510

Funding Number: RFA DK 22 510
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $220,000
Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed) Apply for RFA DK 23 019

Funding Number: RFA DK 23 019
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Integration of Novel Measures for Improved Classification of Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) Apply for RFA DK 23 020

Funding Number: RFA DK 23 020
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,000,000
Undergraduate Summer Research Education in Kidney, Urologic, and Hematologic Diseases (R25 Clinical Trial Not Allowed) Apply for RFA DK 23 013

Funding Number: RFA DK 23 013
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $130,000
Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed) Apply for RFA DK 23 008

Funding Number: RFA DK 23 008
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,200,000
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) Apply for RFA DK 23 014

Funding Number: RFA DK 23 014
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA DK 22 513

Funding Number: RFA DK 22 513
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,000,000
Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed) Apply for RFA DK 22 512

Funding Number: RFA DK 22 512
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed) Apply for RFA DK 22 036

Funding Number: RFA DK 22 036
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $300,000
A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed) Apply for RFA DK 23 001

Funding Number: RFA DK 23 001
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $400,000
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) Apply for PAR 23 248

Funding Number: PAR 23 248
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Single Source for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center (U24 Clinical Trial Required) Apply for RFA DK 23 516

Funding Number: RFA DK 23 516
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $1,000,000
Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional) Apply for RFA DK 23 018

Funding Number: RFA DK 23 018
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 23 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: